Zobrazeno 1 - 10
of 54
pro vyhledávání: '"Rakhee Vaidya"'
Autor:
Tamara K. Moyo, Rakhee Vaidya
Publikováno v:
Frontiers in Oncology, Vol 14 (2024)
Historically, salvage chemoimmunotherapy with consolidative autologous hematopoietic stem cell transplantation (ASCT) was the only potentially curative therapeutic option for patients with relapsed/refractory large B-cell lymphoma (LBCL). Treatment o
Externí odkaz:
https://doaj.org/article/2376ea78838d43c7b52a2cec53a03c69
Autor:
Ellen D. McPhail, Matthew J. Maurer, William R. Macon, Andrew L. Feldman, Paul J. Kurtin, Rhett P. Ketterling, Rakhee Vaidya, James R. Cerhan, Stephen M. Ansell, Luis F. Porrata, Grzegorz S. Nowakowski, Thomas E. Witzig, Thomas M. Habermann
Publikováno v:
Haematologica, Vol 103, Iss 11 (2018)
High-grade B-cell lymphomas with MYC and BCL2 and/or BCL6 rearrangements (double-/triple-hit lymphoma) have an aggressive clinical course. We investigated the prognostic value of transformation from low-grade lymphoma, cytological features (high grad
Externí odkaz:
https://doaj.org/article/51bf1a7568c5469893dfbff05911e177
Autor:
Anne Wofford, Mary B Seegars, Jonathan Lambird, Rakhee Vaidya, Scott Isom, LeAnne Kennedy, Zachariah A McIver, Dianna S. Howard
Publikováno v:
Transplantation and Cellular Therapy. 29:S239-S240
Autor:
Rebecca Merrill, Meaghan Puckett, William Patrick Morrow, Eric D. Hsi, Jason Powell, Zhongyu Li, Rakhee Vaidya, Roy Strowd
Publikováno v:
Neurology. 99(13)
Wrist drop is a common presentation in neurology. To localize the lesion, clinicians can focus on testing finger extension, elbow flexion with semipronated forearm, and elbow extension among other muscle groups and identifying dermatomes of numbness.
Autor:
Anne Wofford, Mary B Seegars, Jonathan Lambird, Rakhee Vaidya, Scott Isom, LeAnne Kennedy, Zachariah A McIver, Dianna S. Howard
Publikováno v:
Transplantation and Cellular Therapy. 28:S260-S261
Autor:
Rakhee Vaidya, Rebecca Damron, Melanie Hooker, Michelle Payne, Mary B Seegars, Dianna S. Howard, Joshua D Brown
Publikováno v:
Transplantation and Cellular Therapy. 28:S459-S460
Autor:
Kavya Kannan, Rakhee Vaidya, Natalie S Grover, Anne W. Beaven, Dominic T. Moore, Jonathan Galeotti, Christopher Dittus, Nathan D. Montgomery, Timothy J Voorhees
Publikováno v:
Leukemialymphoma. 62(1)
Monomorphic post-transplant lymphoproliferative disorder (M-PTLD) occurring after solid organ transplant histologically resembles aggressive non-Hodgkin lymphomas, with diffuse large B-cell lymphoma being the most common. In a cohort of 40 patients w
Autor:
Rachel Kositsky, Andrew Ip, Shakthi Bhaskar, Rakhee Vaidya, Andre Goy, Ahmed Galal, Tushar Dave, Nirav N. Shah, Charalambos Andreadis, Deborah M. Stephens, Eric D. Hsi, Kavya Kannan, Swetha Kambhampati, Boyu Hu, Kenneth Ofori, Matthew McKinney, Sandeep S. Dave, Chrissie Rozzi, Caroline J Roth, Robert Ferdman, Joanna C. Zurko, Nilanjan Ghosh, John M. Pagel, Brian T. Hill, Ellen K. Kendall, Ashley M. Cunningham, Elizabeth Thacker, Neil Bailey, Jadee L. Neff, Matthew Chiaramonte, George Chen, Alexandra E. Kovach, Robert S. Ohgami, Govind Bhagat, Ran Reshef, Olalekan O. Oluwole, Tarsheen K. Sethi, Agrima Mian, Cassandra Love, Sarah L. Ondrejka, Lanie Happ, Clay Parker, Francisco J. Hernandez-Ilizaliturri, Monalisa Ghosh, Krish Patel, Emily F. Mason, Christopher Pallas
Publikováno v:
Blood. 138:165-165
INTRODUCTION Diffuse large B-cell lymphoma (DLBCL) represents several distinct clinical pathologic entities recently identified by molecular profiling. Treatment with anti-CD19 chimeric antigen receptor (CAR) T-cell therapies is now standard for many
Autor:
Bayard L. Powell, Elizabeth Forbes, Enzo Palma, Timothy S. Pardee, Qianqian Song, Rakhee Vaidya, Wei Zhang, Ashley Ballard
Publikováno v:
Blood. 138:2263-2263
Introduction: Chimeric antigen receptor-based T cell therapy (CAR-T) has shown great promise in B cell malignancies. CD30-targeted therapies like brentuximab vedotin have activity in T cell malignancies expressing CD30. There is interest in developin
Autor:
Jing Li, Rakhee Vaidya, Travis S. Young, Carolyn Mulroney, Ian W. Flinn, Jonathan Strauss, Vadim Klyushnichenko, Koen van Besien, Peter A. Riedell, Eduardo Laborda, Jose C. Cruz, Liana Nikolaenko, Mohit Trikha, Peter G. Schultz, Michael Emde
Publikováno v:
Blood. 138:2822-2822
BACKGROUND: CD19 targeted chimeric antigen receptor (CAR) T cells are a transformative treatment option for patients with relapsed, refractory B cell malignancies. Despite remarkable responses in heavily pretreated patients, challenges remain related